Eesti - eesti - Ravimiamet

accord healthcare b.v. - tselekoksiib - kõvakapsel - 100mg 10tk; 100mg 20tk; 100mg 100tk; 100mg 40tk; 100mg 50tk; 100mg 30tk; 100mg 60tk; 100mg 1tk

Eesti - eesti - Ravimiamet

first pharma oÜ - tselekoksiib - kõvakapsel - 200mg 30tk

Eesti - eesti - Ravimiamet

ideal trade links uab - tselekoksiib - kõvakapsel - 200mg 20tk

Eesti - eesti - Ravimiamet

ideal trade links uab - tselekoksiib - kõvakapsel - 200mg 30tk; 200mg 20tk; 200mg 100tk; 200mg 40tk; 200mg 50tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

oncopeptides ab - melphalan flufenamide hydrochloride - mitu müeloomit - antineoplastilised ained - pepaxti is indicated, in combination with dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least three prior lines of therapies, whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one anti-cd38 monoclonal antibody, and who have demonstrated disease progression on or after the last therapy. for patients with a prior autologous stem cell transplantation, the time to progression should be at least 3 years from transplantation (see section 4.

Euroopa Liit - eesti - EMA (European Medicines Agency)

lipomed gmbh - talidomiid - mitu müeloomit - immunosupressandid - thalidomide lipomed in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged ≥ 65 years or ineligible for high dose chemotherapy. thalidomide lipomed is prescribed and dispensed in accordance with the thalidomide lipomed pregnancy prevention programme (see section 4.

Eesti - eesti - Ravimiamet

inteli generics nord uab - tselekoksiib - kõvakapsel - 200mg 30tk; 200mg 40tk; 200mg 10tk; 200mg 100tk; 200mg 60tk; 200mg 20tk

Eesti - eesti - Ravimiamet

inteli generics nord uab - tselekoksiib - kõvakapsel - 100mg 100tk; 100mg 40tk; 100mg 20tk; 100mg 10tk